DelSite Biotechnologies, Inc. Reports Third Quarter 2008 Results

IRVING, TX--(Marketwire - November 13, 2008) - DelSite, Inc. (OTCBB: DSII) today reported total revenue from continuing operations for the quarter ended September 30, 2008 of $2.2 million, compared to revenue of $2.9 million in the year-ago period, a decrease of 24 percent, after accounting for a roughly 90 percent decrease in grant revenue for the Company's DelSite Biotechnologies subsidiary due to the near completion of grant-funded studies.